It's a big day for Novo Nordisk (NVO) as its CEO Lars Fruergaard J?rgensen testified Tuesday on Capitol Hill over the drugmaker's GLP-1 prices. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Wealth! to discuss what lawmakers said about Novo Nordisk's pricing.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written and updated by Melanie Riehl